QCI Asset Management’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-500
Closed -$1K 535
2020
Q1
$1K Hold
500
﹤0.01% 580
2019
Q4
$1K Hold
500
﹤0.01% 586
2019
Q3
$1K Buy
+500
New +$1K ﹤0.01% 573

QCI Asset Management's SVNT Position: Q2 2020 in Review

QCI Asset Management sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q2 2020, closing a stake of 500 shares — an estimated $1K sold.

QCI Asset Management first reported a position in SVNT in Q3 2019 and held it in 3 quarters. The position peaked at $1K in Q1 2020. 1 fund tracked by Wall St. Rank holds SVNT as of Q2 2020.

  • QCI Asset Management reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q2 2020 after selling out during the quarter.
  • QCI Asset Management sold 500 SAVIENT PHARMACEUTICALS INC shares in Q2 2020, an estimated $1K.
  • QCI Asset Management first reported a position in SAVIENT PHARMACEUTICALS INC in Q3 2019 and held it in 3 quarters.
  • QCI Asset Management's SAVIENT PHARMACEUTICALS INC position peaked at $1K in Q1 2020.
  • 1 fund tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q2 2020.

Based on QCI Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.